FDA sets 27 June as verdict date for Arena weight-loss drug
This article was originally published in Scrip
Executive Summary
The US FDA will determine the fate of Arena Pharmaceuticals' weight-loss drug lorcaserin by 27 June in the second go-round for the company on the drug's application, which was rejected in October 2010.